Scalable System-Wide CYP2C19 Pharmacogenomic Testing Reveals 38% Excess Incidence of Adverse Events in Metabolizers Receiving Inappropriate Prescriptions

Scritto il 22/04/2026
da Natalie Telis

No abstract

Circ Genom Precis Med. 2026 Apr 22:e005363. doi: 10.1161/CIRCGEN.125.005363. Online ahead of print.

NO ABSTRACT

PMID:42017228 | DOI:10.1161/CIRCGEN.125.005363